Industry | 2022.06.17
Generis celebrates new milestones as swathes of the global pharma industry default to CARA Life Sciences™ to manage critical data and content
Mid-sized companies & smaller biotechs join big names including Merck and Pfizer to manage data, content & processes via the single, cloud-based, SaaS platform & information lake. Japan, the world’s second-largest pharma market, embraces CARA Life Sciences at a quickening pace, with a six-fold increase in adoption across the country as word spreads. CARA unique user numbers top 750,000 worldwide, with over 2 billion documents & data objects now managed in CARA. Numbers of customers & systems deployed have doubled over the last 12-18 months. Generis staff numbers have trebled to cope with demand. ‘Build’ partnerships are rocketing too, as application leaders choose to base next-generation products on CARA, to smooth content flow between functions for customers.
(PRWeb June 17, 2022)
Read the full story at https://www.prweb.com/releases/2022/06/prweb18741646.htm
For more information, please visit
https://www.prweb.com/releases/2022/06/prweb18741646.htm
